featured case report

The Use of a Lyophilized dCHPM Allograft in a Venous Ulcer

View Report
Revita

The First Complete Placental Membrane Allograft

Revita is a lyophilized dehydrated complete human placental membrane (dCHPM) allograft intended for use as a wound covering or barrier membrane for both acute and chronic wounds. Through the patented Clearify® technology, Revita allografts retain the complete native placental membrane, including all three layers (the amnion, intermediate layer, and chorion), while also preserving key extracellular matrix components.1
 

Never delaminated
4x thicker, 6x more growth factors, 4x more protein than the competitor graft1,2
Over 875 cytokines and growth factors measured1
Retains key component concentrations that closely resemble that of native tissue3

Case Reports

Watch the use of Revita in a Venous Ulcer.

Download Case Report 

The Use of Lyophilized dCHPM Allograft in Recurrent Basal Cell Carcinoma Excision

A 74-year-old male underwent an excision procedure for a recurrent basal cell carcinoma on his occipital scalp, resulting in a wound measuring 2.8 cm x 1.3 cm. The wound was resolved after 3 applications of dCHPM.
view report

The Use of a Lyophilized dCHPM Allograft in a Diabetic Ulcer

A 58-year-old female presented with a Diabetic Foot Ulcer (DFU) on the plantar aspect of her right heel. The wound had failed previous therapies for approximately 2 years prior to the use of lyophilized dCHPM allografts. The wound was completely resolved after just 2 applications of dCHPM.
view report

The Use of a Lyophilized dCHPM Allograft in a Venous Ulcer

An 87-year-old female presented with a severe venous ulcer. The wound measured 11 cm in length and 4 cm in width with exposed tendon and heavy exudate. After 4 applications of dCHPM, the wound was completely resolved.
view report

Common Clinical Applications

Wound Types*

Acute and chronic wounds such as:

  • Dermatologic Wounds
  • Diabetic Ulcers
  • Pressure Ulcers
  • Surgical Wounds
  • Traumatic Wounds
  • Venous Ulcers
*Revita is intended to be used as a wound covering or barrier membrane.
Specialties

Commonly used in specialties such as:

  • Dermatology
  • General Surgery
  • Orthopedic Surgery
  • Plastic Surgery
  • Podiatry
  • Vascular Surgery

Common Anatomical Applications

Sizes & SKUs

Size 15 mm disk 2 x 2 cm 2 x 3 cm 4 x 4 cm 4 x 6 cm 2 x 12 cm 6 x 6 cm 6 x 8 cm
SKU RV-0015 RV-2020 RV-2030 RV-4040 RV-4060 RV-0212 RV-6060 RV-6080

Sheet Format  |  Shelf-stable for up to five (5) years

Related Resources

1. Data on file.

2. Data is compared to the leading dual-layer and reported as an average.

3. Roy, A., & Griffiths, S. (2020). Intermediate layer contribution in placental membrane allografts. Journal of Tissue Engineering and Regenerative Medicine, 14(8), 1126–1135. https://doi.org/10.1002/term.3086

4. Manna B, Cooper JS. Radiation Therapy Induced Skin Ulcer. [Updated 2021 Jul 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing: 2021 Jan-.

5. J. Bradford Rice, Urvi Desai, Alice Kate G. Cummings, Howard G. Birnbaum, Michelle Skornicki & Nathan Parsons (2014) Burden of venous leg ulcers in the United States, Journal of Medical Economics, 17:5, 347-356, DOI: 10.3111/13696998.2014.903258

6. J. Bradford Rice, Urvi Desai, Alice Kate G. Cummings, Howard G. Birnbaum, Michelle Skornicki & Nathan Parsons (2014) Burden of venous leg ulcers in the United States, Journal of Medical Economics, 17:5, 347-356, DOI: 10.3111/13696998.2014.903258

Patents: www.stimlabs.com/patents

logos_StimLabs_web

© 2016-2024 Stimlabs® LLC; STIMLABS, REVITA, COGENEX, ENVERSE, VIALIZE, RELESE, and CLEARIFY are registered trademarks of Stimlabs LLC. 

Join our mailing list

This field is for validation purposes and should be left unchanged.